GENTILUCCI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 6.803
EU - Europa 6.388
AS - Asia 2.982
AF - Africa 491
SA - Sud America 17
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 16.697
Nazione #
US - Stati Uniti d'America 6.770
IT - Italia 2.008
GB - Regno Unito 1.442
CN - Cina 1.290
SG - Singapore 762
DE - Germania 713
VN - Vietnam 436
SE - Svezia 381
UA - Ucraina 369
RU - Federazione Russa 321
FR - Francia 282
IN - India 260
IE - Irlanda 229
TG - Togo 205
NL - Olanda 184
CI - Costa d'Avorio 121
ZA - Sudafrica 110
BG - Bulgaria 91
EE - Estonia 87
FI - Finlandia 75
JO - Giordania 67
CH - Svizzera 53
HK - Hong Kong 45
BE - Belgio 36
CA - Canada 30
SC - Seychelles 26
NG - Nigeria 25
ES - Italia 24
HR - Croazia 24
JP - Giappone 21
ID - Indonesia 19
IR - Iran 17
LB - Libano 16
RO - Romania 16
AT - Austria 14
PK - Pakistan 12
AU - Australia 9
CL - Cile 9
TR - Turchia 9
GR - Grecia 8
PL - Polonia 8
BR - Brasile 7
EU - Europa 6
CZ - Repubblica Ceca 5
PT - Portogallo 5
IL - Israele 4
IQ - Iraq 4
TW - Taiwan 4
BD - Bangladesh 3
LT - Lituania 3
NO - Norvegia 3
SI - Slovenia 3
TH - Thailandia 3
TN - Tunisia 3
MX - Messico 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
MW - Malawi 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 16.697
Città #
Southend 1.248
Fairfield 768
Singapore 622
Chandler 604
Ashburn 538
Santa Clara 519
Bologna 395
Woodbridge 375
Seattle 340
Wilmington 339
Princeton 300
Cambridge 285
Houston 283
Ann Arbor 265
Dong Ket 264
Jacksonville 262
Dublin 220
Lomé 205
Boardman 182
Nanjing 152
Padova 131
Westminster 131
Milan 128
Abidjan 121
Berlin 98
Sofia 91
Beijing 87
Jinan 84
Amman 67
Helsinki 67
Shenyang 67
Saint Petersburg 64
Bremen 61
Shanghai 55
Hebei 50
Guangzhou 49
Medford 49
Mülheim 46
Changsha 45
San Diego 45
Turin 44
Rome 42
Redmond 40
Nanchang 38
New York 36
Zhengzhou 36
Tianjin 35
Brussels 34
Haikou 31
Hangzhou 31
Des Moines 27
Mountain View 27
Falkenstein 25
Mahé 25
Yubileyny 25
Abeokuta 24
Cesena 24
Hong Kong 24
Los Angeles 24
Redwood City 24
Wuhan 24
Forlì 23
Bari 21
Florence 20
Frankfurt am Main 20
Jiaxing 19
Norwalk 19
Modena 18
Verona 18
Falls Church 17
Jakarta 17
Ningbo 17
Boydton 16
Forlimpopoli 16
Pessac 16
San Mauro Pascoli 16
Tokyo 16
Toronto 16
Zurich 16
Kunming 15
San Venanzo 15
Taizhou 15
Chicago 14
Phoenix 14
Shenzhen 14
Chengdu 13
Dearborn 13
Düsseldorf 13
Taiyuan 13
Bern 12
Davis 12
Fremont 12
Imperia 12
London 12
Paris 12
Parma 12
Naples 11
Washington 11
Lanzhou 10
Olalla 10
Totale 10.928
Nome #
Inibitori dei processi infiammatori cronici connessi allo sviluppo di tumori (Inhibitors of the chronic inflammatory processes connected to tumor development) 658
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration 192
Targeting integrins αvβ3 and α5β1 with new β-lactam derivatives 190
Dehydro-beta-proline Containing Alpha-4-beta-1 Integrin Antagonists: Stereochemical Recognition in Ligand-Receptor Interplay 187
A novel family of minimal PMRI cyclic peptides as versatile scaffolds for generating new molecular topology. 185
A simple route towards peptide analogues containing substituted (S)- or (R)-tryptophans 178
Modern tools for the chemical ligation and synthesis of modified peptides and proteins 178
Thixotropic peptide-based physical hydrogels applied to three-dimensional cell culture 176
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 175
A convenient synthesis of functionalized isoxazolines and related 5-hydroxy-isoxazolidine-4-carboxylates 172
A novel family of minimalist opioid peptides deprived of the classic pharmacophores 169
5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists 169
A microwave-enhanced, Lewis acid-catalyzed synthesis of 1,3-dioxolanes and oxazolines from epoxides 160
Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization 158
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 155
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES 151
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics 150
An improved microwave assisted protocol for Yonemitsu-type trimolecular condensation 145
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 145
Practical synthesis of 3-bromo-5,6-dihydropyridin-2-ones via β,γ-unsaturated α-bromo-ketene/imine cycloaddition 144
Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity? 144
A straightforward route to enantiopure 2-substituted-3,4-dehydro-beta-proline via ring closing metathesis 142
Green synthesis of bioactive oligopeptides promoted by recyclable nanocrystalline hydroxyapatite 142
Highly Regio- and Diastereoselective Palladium-Catalyzed Allylic Substitution. Synthesis of 3-(2-aminobutylidene)-4-arylazetidin-2-ones 140
An investigation of the reactivity of MCPBA and alpha-bromoalkenes under traditional or microwave-assisted conditions: Selective formation of epoxides or allylic bromides. 139
Controlling Cyclopeptide Backbone Conformation with β/α-Hybrid Peptide–Heterocycle Scaffolds 139
Asymmetric Synthesis of three and four membered ring heterocycles 138
alpha-Bromo-beta,gamma-unsaturated Ketenes as Valuable Intermediates in the Synthesis of alpha-Amino-beta,gamma-Unsaturated Acids 137
DESIGN AND SYNTHESIS OF OPIOID PEPTIDE ANALOGUES AND MIMETICS 137
Convenient Synthesis of the Antibiotic Linezolid via an Oxazolidine-2,4-dione Intermediate Derived from the Chiral Building Block Isoserine 137
Diagnostic implementation of fast and selective integrin-mediated adhesion of cancer cells on functionalized zeolite L monolayers 136
Integrin-targeting dye-doped peg-shell/silica-core nanoparticles mimicking the proapoptotic Smac/DIABLO protein 136
Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects 136
Exploring the reactivity of alkylidene malonamides: synthesis of polyfunctionalized isoxazolidinones, aziridines and oxazolines 135
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 132
Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation 132
Zinc Metal-Promoted Nucleophilic Addition of Azetidin-2-ones to Aldehydes and Nitriles 131
Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus 129
Design of α/β-hybrid peptide ligands of α4β1 integrin equipped with a linkable side chain for chemoselective biofunctionalization of microstructured materials 129
New trends in the development of opioid peptide analogues as advanced remedies for pain relief 128
Dehydro-beta-amino Acid Containing Peptides as Promising Sequences for Drug Development 128
Synthesis and Biological Evaluation of Azido- and Aziridino-hydroxyl-beta -lactams through Stereo- and Regioselective Epoxide Ring Opening. 125
Modulation of αvβ3- and α5β1-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics 125
Asymmetric Synthesis of Three and Four Membered Ring Heterocycles - Chapter 1 124
Highly regio- and stereoselective palladium-catalyzed allylic carbonate amination. A practical route to dehydro-beta-amino esters 122
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics 122
Enzymatic Resolution of Ethyl 3-Hydroxy-2(1'substituted-methylidene)-butyrate by Pseudomonas Cepacia Lipase Catalyzed Acetylation 122
Synthesis and evaluation of the affinity toward mu-opioid receptor of atypical, lipophilic ligands based on the sequence c[Tyr-Pro-Trp-Phe-Gly-]. 121
The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists. 121
Cyclotetrapeptide Mimics based on a 13-Membered, Partially Modified Retro-Inverso Structure 121
Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics. 121
Synthesis and assay of retro-α4β1 integrin-targeting motifs 120
In-peptide synthesis of di-oxazolidinone and dehydroamino acid-oxazolidinone motifs as β-turn inducers 120
Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions 120
Lewis acid induced highly regioselective synthesis of a new class of substituted isoxazolidines 119
Synthesis of dehydro-beta-amino esters via highly regioselective amination of allylic carbonates 118
Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists. 117
Unusual Amino Acids: Synthesis and Introduction into Naturally Occurring Peptides and Biologically Active Analogues 116
Synthesis and Biological Evaluation of Nonpeptide alpha-v-beta-3/alpha-5-beta-1 Integrin Dual Antagonists containing 5,6-Dihydropyridin-2-one Scaffolds 116
Investigation of the Interaction Between the Atypical Agonist c[YpwFG] and MOR 116
Controlled solid phase peptide bond formation using N-carboxyanhydrides and PEG resins in water. 116
Highly Diastereoselective Allylic Azide Formation and Isomerization. Synthesis of 3(2'-Amino)-beta-lactams 115
Heterocyclic Scaffolds in the Design of Peptidomimetic Integrin Ligands: Synthetic Strategies, Structural Aspects, and Biological Activity 115
Peptide bond formation using unprotected N-carboxyanhydrides under green chemistry conditions 115
Development of isoxazoline-containing peptidomimetics as dual alpha-v-beta-3 and alpha-5-beta-1 integrin ligands. 114
Cyclopeptide analogs for generating new molecular and 3D diversity 114
Synthesis of chiral non-racemic intermediates and Arg-Gly-Asp mimetics by CaLB-catalyzed resolution 111
Peptides and peptidomimetics in medicine, surgery, and biotecnology 109
Synthesis of Ethyl 5-Hydroxyisoxazolidine-4-carboxylates via Michael Addition/Intramolecular Hemiketalisation 109
Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-d-alanine 108
PacDOCK: A Web Server for Positional Distance-Based and Interaction-Based Analysis of Docking Results 108
Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects 107
Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold 107
NEW PEPTIDOMIMETIC α4β1-INTEGRIN ANTAGONISTS FOR REDUCING INFLAMMATION AND ALLERGIC REACTIONS 106
Dehydro-beta-amino acids as scaffolds for the preparation of alpha-v-beta-3, alpha-5-beta-1 and alpha-4-beta-1 integrin ligands 105
null 105
Preparation of Non-Toxic Fluorescent Peptide-Coated Silica/PEG Nanoparticles from Peptide-Block Copolymer Conjugates 104
DETERMINATION OF THE BIOLOGICALLY ACTIVE STRUCTURE OF THE ATYPICAL MOR-LIGAND c[D-Asp-1-amide-beta-Ala-D-Trp-Phe] AND ANALOGUES BY NMR AND MOLECULAR DOCKING 104
Stereoselective synthesis of a new class of spiro-beta-lactams via epoxide ring opening 103
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 103
Functionalizations of the C3 side chain of densely substituted azetidin-2-ones 102
Atypical mu-opioid agonists: reconsideration of the requisites for receptor activation 102
Stereoselective synthesis of a new class of spiro-beta-lactams via epoxide ring opening 101
Synthesis and biological evaluation of unprecedented classes of spiro-beta-lactams and azido-beta-lactams as acyl-CoA:cholesterol acyltransferase inhibitors 101
Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief 101
Short peptidomimetics containing heterocyclic scaffolds as alpha-v-beta-3 integrins ligands. 101
Synthesis of Enantiomerically Pure alpha-v-beta-3 Integrin ligands Based on a 5,6-Dihydropyridin-2-one Scaffold. 100
Stereoselective Synthesis of Linear and Cyclic Dehydro-beta-amino Acids for the Preparation of alpha-v-beta-3 and alpha-5-beta-1 Integrin Inhibitors 99
Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans 98
Synthesis and Conformational Analysis of Cyclotetrapeptide Mimetic beta-Turn Templates and Validation as 3D Scaffolds 98
Current Medicinal Chemistry 97
Alkylidene malonamides and acetacetamides as intermediates for the preparation of constrained dipeptide mimetics. 97
One-Pot Synthesis of Poly-Substituted Tetramic Acids for the Preparation of Reverse-Turn Mimics 97
Synthesis and Analysis of the Conformational Preferences of 5- Aminomethyloxazolidine-2,4-dione Scaffolds: First Examples of beta2- and beta2,2-Homo-Freidinger Lactam Analogues 97
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 97
Design and synthesis of Alpha-v-beta-3 and Alpha-5-beta-1 integrin ligands as delivery systems for fluorescent molecules 96
Interactions between atypical opioid agonists and MOR 96
Biologically active analogues of naturally occurring peptides 95
Synthesis of Constrained Peptidomimetics Containing 2-Oxo-1,3-oxazolidine-4-carboxylic Acids 94
Purification from Deinococcus radiodurans of a 66 kDa ABC transporter acting on peptides containing at least 3 amino acids 94
Totale 13.111
Categoria #
all - tutte 47.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020570 0 0 0 0 0 0 0 0 0 258 93 219
2020/20212.201 420 122 101 153 41 113 146 170 229 125 134 447
2021/20222.705 343 155 186 132 262 146 95 294 107 148 409 428
2022/20233.089 264 447 156 382 224 261 119 161 592 91 236 156
2023/20241.376 91 135 80 119 169 284 101 98 43 99 83 74
2024/20253.236 192 599 379 241 767 250 401 118 37 252 0 0
Totale 17.119